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Pyloric stenosis (PS), also known as infantile hypertrophic PS, is the most common condition requiring 
surgery in the first months after birth.1 The condition is caused by hypertrophy of the smooth circular 
muscle layer of the pyloric muscle, obstructing the gastric outlet to the small intestine and leading to 
severe postprandial vomiting. In Ramstedt pyloromyotomy, the circular muscle is incised longitudinally 
without closure, typically relieving the obstruction permanently.2 The incidence of PS in Denmark is 1 to 
2 per 1000 live births.3, 4 
Although the clinical presentation, diagnosis, and treatment of PS are well-established, the etiology 
remains unclear. Male gender3, 5–7 and a family history of PS 3, 5, 6, 8 are consistently reported risk factors 
and suggest a genetic component to the etiology.3, 6 However, the change in PS incidence reported in 
several countries9 indicates that environmental factors are also important. Symptoms usually do not 
arise until the second or third week after birth10 and only exceptionally before,11 suggesting that early 
exposures such as feeding practices could be important risk factors. In Denmark, the frequency of 
breastfeeding increased during the 1990s. In the same period, the incidence of PS in Denmark 
decreased.4, 12 
Parallels between breastfeeding and PS risk have been documented in other countries raising discussion 
about whether breastfeeding protects or is a risk factor for PS.13–18 Two case-control studies revealed a 
two- to threefold higher risk for infants being bottle-fed.19, 20 The authors of these studies examined the 
association between feeding practice at the time of postdelivery discharge or the first week after birth 
and the subsequent risk of PS. However, PS onset is typically between 3 and 8 weeks of age,7 several 
weeks after this feeding information was obtained. Thus, mothers classified as breastfeeding soon after 
discharge may have changed to bottle-feeding well before the onset of PS symptoms, thereby likely 
underestimating the risk of PS with respect to bottle-feeding. Using data from a nationwide birth cohort, 
we were able to examine in detail the association between the timing of first exposure to bottle-feeding 
and the subsequent risk of PS. 
 
Methods 
Study Cohort 
The study was based on the Danish National Birth Cohort,21 which enrolled 101 042 pregnancies in 
91 827 Danish women during the period from 1996 to 2002. Twice during pregnancy (weeks 12 and 30) 
and twice after delivery (6 months and 18 months), women were interviewed by telephone to obtain 
detailed exposure data. 
For the current study, inclusion criteria required being a live-born singleton infant included in the Danish 
National Birth Cohort and having a mother who answered the questions about feeding practice in the 6-
month interview. In total, 70 148 infants fulfilled these criteria. The reduction in numbers occurred 
largely because participation in the study decreased at each interview (92% participated in the first 
interview, 87% in the second interview, and 70% in the third interview) but also because multiple-birth 
infants were excluded. Multiple births were excluded because they are special pregnancies with a higher 
risk of PS.3 
Exposure 
Information on feeding practice was obtained from the 6-month telephone interview. In this interview, 
the mothers were asked (1) whether they were currently breastfeeding, (2) for how long they had fully 
breastfed their children, and (3) how old their children were when they stopped breastfeeding. The 
mothers indicated the length of breastfeeding in days, weeks (7 days), or months (30.5 days) plus weeks, 
but all answers were translated into days from birth. We assumed that all infants <4 months of age who 
were not fully breastfed were bottle-fed. Thus all infants who were not fully breastfed are labeled as 
bottle-fed infants. Only 48 women (no PS cases) in our study gave their own (45 women) or another 
mother’s milk (3 women) by bottle. We therefore assumed that the bottle-fed infants were fed artificial 
formula milk. Information on the brand of formulas was not available from the interview. 
Outcome 
Information on PS diagnosis was obtained from the Danish National Patient Register.22 PS cases were 
defined as infants who had a pyloromyotomy determined by the following surgery codes: KJDH60 and 
KJDH61 (Nordic Classification of Surgical Procedures). Of the 101 042 pregnancies enrolled in the Danish 
National Birth Cohort, 75 infants had a surgery code for PS. Thirty-two infants had a diagnosis code for 
PS according to the Danish National Patient Register (Q40.0, DK31.1, K31.1A, DK31.3, and DK31.8B 
[International Classifications of Diseases, 10th Revision]), but no codes documented surgery for PS. Their 
medical files were individually reviewed, and when a definite record of surgery for PS was found, the 
child was included as a case (14 cases). Of the 89 cases, 3 cases were not singleton, 20 cases were 
missing information about feeding practice from the 6-month interview, and 1 case was diagnosed at 
age 5 months, resulting in 65 PS cases included in the study. Date of PS diagnosis was defined as the 
date of first admission for PS diagnosis. 
Covariates 
From the telephone interviews, we gathered information on mothers’ socioeconomic status (occupation 
and years of schooling) and smoking habits. Information on the infant’s gender, date and place of birth, 
maternal age, birth order, emigration, and updated information on vital status was obtained from the 
Danish Civil Registration System, data being available since April 1968. The Danish Civil Registration 
System includes a unique personal identification number assigned to each Danish resident permitting 
accurate linkage of individual-level information between the nationwide registers in Denmark.23 Data on 
gestational age, birth weight, and type of birth were based on information from the Danish Medical 
Birth Registry.24 
Statistical Analysis 
The association between bottle-feeding and the risk of PS was evaluated by hazard ratios (HRs) 
estimated in a Cox regression model by using PROC TPHREG in SAS software, version 9.1 (SAS Institute, 
Inc, Cary, NC). Age was used as the underlying time scale and, unless otherwise stated, all HRs were 
adjusted for gender, gestational age (<37, 37–<42, and ≥42 weeks), birth weight (<2500, 2500–<3000, 
3000–<3500, 3500–<4000, 4000–<4500, and ≥4500 g), birth order (1, 2, and 3+), maternal age (<25, 25–
<30, 30–<35, and ≥35 years), and maternal smoking during pregnancy. Infants were considered at risk 
from birth to 4 months of age, death, emigration, or PS diagnosis, whichever occurred first. 
Based on the answers from the questions about feeding practice in the 6-month interview, we defined 
the child’s age at change from full breastfeeding to both breast and bottle-feeding and the age at 
change from both breast and bottle-feeding to exclusive bottle-feeding. These ages were used to define 
the time-dependent feeding practice variables (ie, combination of breast and bottle-feeding, time since 
first exposure to bottle-feeding, and age at first exposure to bottle-feeding) for every day during follow-
up. Analyses of effect modification by gender and attained age of child were conducted by including an 
interaction term in the Cox regression model. The assumption of proportional hazards in the Cox 
regression model was evaluated by the effect modification with attained age. All tests were 
homogeneity Wald test. Cumulative risk of PS by age in months was estimated by the Kaplan–Meier 
estimates. 
The association between case status (case versus noncase) and whether the mother reported time of 
first exposure to bottle-feeding in days, weeks, or months plus weeks was evaluated by logistic 
regression with adjustment for age at exposure to first bottle-feeding, using the procedure GENMOD in 
SAS. 
Ethics 
Women in the study gave consent to participation, and permission to perform the analyses was granted 
by the Danish National Birth Cohort steering committee and the Danish Data Protection Board. 
 
Results 
The cohort of 70 148 singleton infants was followed for 4 months during which 65 infants had surgery 
for PS, which amounts to an overall risk of 0.1%. Of the 65 PS cases, 59 (91%) were boys and 6 (9%) were 
girls. The median age at diagnosis was 35 days (minimum: 9; maximum: 96), and 95% of the cases were 
diagnosed between 13 and 69 days of age. Of the 65 PS cases, 29 infants were bottle-fed before PS 
diagnosis. Among ever breastfed infants, the median age at first exposure to bottle-feeding was 91 days 
for PS cases and 122 days for noncases. Follow-up included 4781 person-years for bottle-fed infants 
(with or without breastfeeding in addition) and 18 635 person-years for infants while not bottle-fed. 
Table 1 shows the HRs of PS according to feeding practice characteristics. The overall HR of PS for infants 
who were bottle-fed compared with infants who were not bottle-fed was 4.62 (95% confidence interval 
[CI]: 2.78–7.65). Among the bottle-fed infants, there were no significant differences in risk between the 
both breast and bottle-fed (HR: 3.36 [95% CI: 1.60–7.03]), the formerly breastfed (HR: 5.38 [95% CI: 
2.88–10.06]), and the never breastfed infants (HR: 6.32 [95% CI: 2.45–16.26]) (P = .76). Furthermore, the 
increased risk of PS among infants who were bottle-fed was observed even after 14 days, as well as 30 
days since first exposure to bottle-feeding. Among both breast and bottle-fed infants, we observed an 
HR of 4.35 (95% CI: 1.70–11.20) with <14 days of exposure to bottle-feeding and 2.60 (95% CI: 0.91–
7.41) with >14 days of exposure to bottle-feeding. The risk of PS among bottle-fed infants did not vary 
with age at first exposure to bottle-feeding. 
Table 1: HRs of PS According to Feeding Practice Characteristics 
Feeding Practice Characteristics Number of PS Cases HR (95% CI)a P 
Exposure to bottle-feeding    
 Not bottle-fed 36 1 (reference) <.0001 
 Bottle-fed 29 4.62b (2.78–7.65) — 
Combination of breast and bottle-feeding    
 Not bottle-fed 36 1 (reference) — 
 Bottle-fedc    
 Both breast and bottle-fed 9 3.36d (1.60–7.03)  
 Formerly breastfed 15 5.38 (2.88–10.06) .76 
 Never breastfed 5 6.32d (2.45–16.26)  
Time since first exposure to bottle-feedinge    
 Not bottle-fed 36 1 (reference) — 
 Bottle-fed    
  <30 d 18 4.50 (2.53–8.01) 
.98   ≥30 d 11 4.85 (2.33–10.07) 
Age at first exposure to bottle-feeding    
 Not bottle-fed 36 1 (reference) — 
 Bottle-fed    
  <30 d 25 5.00 (2.97–8.41) 
.26   ≥30 d 4 2.95 (0.99–8.72) 
 
• a HR adjusted for age, gender, gestational age, birth weight, birth order, maternal age, and maternal smoking during 
pregnancy. Adjusting only for age increases HR to 5.05 (3.07–8.30), primarily due to not adjusting for maternal 
smoking during pregnancy. 
• b Additionally adjusting for mothers’ socioeconomic status (occupation and school skills), type of birth 
(vaginal/caesarean section) and maternal smoking during breastfeeding, and postnatal yield similar results. 
• c Among the bottle-fed infants, the median age at diagnosis was 40 d for both breast and bottle-feeding infants, and 
35 d for formerly breastfed infants now receiving only bottle-feeding. Five infants with PS were never breast-fed, and 
among them, the age at diagnosis ranged from 13 to 35 d, with a median age of 26 d. Furthermore, among the infants 
who were bottle-fed, the time of follow-up was 2027 person-years for those both breast and bottle-fed, 2332 person-
years for those formerly breastfed, and 422 person-years for those never breastfed (exclusively bottle-fed). 
• d The ratio between the HR for both breast and bottle-fed infants and the HR for never breastfed was 1.88 (0.63–
5.66). 
• e Among the bottle-fed infants, the HR of PS was 4.91 (95% CI: 2.34–10.31) <14 d since first exposure to bottle-
feeding and 4.48 (95% CI: 2.53–7.94) >14 d since first exposure to bottle-feeding. Less than 14 d since first exposure 
to bottle-feeding, there were 9 cases: 3 cases within the first 48 h and 6 cases in the second week. 
 
We found no significant modification of the overall association with bottle-feeding and PS risk according 
to attained age of the infant (<30 days: HR: 5.82 [95% CI: 2.47–13.73]; ≥30 days: HR: 4.12 [95% CI: 2.24–
7.60]; P = .52) or gender of the infant (boy infants: HR: 3.91 [95% CI: 2.29–6.68]; girl infants: HR: 30.09 
[95% CI: 3.50–258.63]; P = .07). 
Figure 1 shows the estimated cumulative risk of PS by age in bottle-fed and in not bottle-fed infants. It 
was estimated that among bottle-fed infants, 0.31% developed PS during the first 4 months after birth 
compared with 0.05% among infants who were not bottle-fed during the first 4 months. 
 
Figure 1: Cumulative risk of PS by age in bottle-fed and not bottle-fed infants. 
 
 
Whether the mother reported time at first exposure to bottle-feeding in days, weeks, or months plus 
weeks was not associated with case status after adjustment for age at first exposure to bottle-feeding (P 
= .29). 
Adjusting covariates for bottle-feeding did not affect the estimates of the covariates. 
 
Discussion 
It is surprising that feeding practice has not been more intensively investigated in relation to PS. It is an 
obvious candidate as an early postnatal risk factor for this disease. In this large cohort study, we found 
that infants who were bottle-fed had a 4.6-fold increased risk of developing PS compared with infants 
who were not bottle-fed, even after adjustment for other known risk factors and possible confounders. 
The increased risk was seen in all bottle-fed groups; in infants who were both breast and bottle-fed, in 
infants who were formerly breastfed, and in infants who were never breastfed (exclusively bottle-fed). 
The role of feeding practice has been examined primarily by ecological studies in which changes in risk 
of PS over time has been correlated with changes in rates of breastfeeding/bottle-feeding.14–17 
Conflicting results have been reported. In 2 older studies in which the authors used survey information, 
bottle-feeding had no impact on PS risk.13, 18 However, a few recent analytical studies have revealed a 
distinct risk association between early bottle-feeding and PS.19, 20, 25 In a 1:1 case-control study, Habbick 
et al19 examined feeding practice at the time of postdelivery discharge and found that bottle-feeding 
was 2.9 times more common among infants who developed PS than among the control subjects. A 
recent 30-year retrospective study of infants diagnosed with PS in Nigeria revealed that all 57 infants 
developing PS in the survey area were infants who used artificial feeds.25 Pisacane et al20 observed that 
infants developing PS were less likely to have been exclusively breastfed during the first week after birth 
compared with control infants. Consistent with our findings, they estimated a similar risk of PS for the 
exclusively formula-fed infants and the both breast and formula-fed infants. 
To our knowledge, no previous studies have evaluated the importance of the timing of first exposure to 
bottle-feeding and the risk of PS or presented the modification of the PS risk according to attained age 
and gender. The prospective design and information on perinatal and feeding practices in the Danish 
National Birth Cohort allowed us such an opportunity. We found no significant difference in the overall 
effect according to these characteristics. Despite small numbers, the 30-fold elevation in HR for girls and 
the nearly eightfold difference in the girl:boy ratio of HRs raises the possibility of an increased female 
susceptibility to bottle-feeding. However, as the baseline rate is much lower in girls, it could simply 
reflect that the rates in boys and girls are similar among bottle-fed infants. This observation needs 
further examination. We found no significant variation of the overall result according to attained age, 
and we found time since first exposure to bottle-feeding similarly increased less and above 30 days. 
We documented a higher risk of PS for bottle-fed infants compared with infants who were not bottle-
fed. Two possible explanations are that either breastfeeding confers protection or bottle-feeding is itself 
the risk factor for PS responsible for the association. 
Under the hypothesis that breast milk confers protection against PS, one suggestion has been that the 
presence of high levels of hormones such as vasoactive intestinal peptide in human milk favor pyloric 
relaxation.20 Breast milk also has lower osmolarity, which could provide better gastric emptying.26 It is 
also theoretically possible that breastfeeding protects against an infectious trigger by unknown agents 
because previous studies have revealed that breastfeeding confers protection against gastrointestinal 
infections.27–29 The protective effect of prebiotics might be contributing. Bifidobacteria and lactobacilli 
make up 90% of the bacteria in the stomach of breastfed infants but only 40% to 60% in bottle-fed 
infants.30–32 However, no infectious cause is known to explain PS.33 
We find it more likely that bottle-feeding is the important feeding risk factor. In support, we 
demonstrated a significant increased risk among both never (sixfold) and formerly breastfed infants 
(fivefold) as compared with infants who were not bottle-fed (fully breastfed). In both bottle-exposed 
groups, infants were exclusively being bottle-fed at PS onset. Among the bottle-fed infants, infants both 
breast and bottle-fed were a mixed group, and the proportion of milk coming from the breast and from 
bottle-feeding, respectively, was not reported. By experience, in the beginning of the both breast and 
bottle-fed period, bottle use may be minimal. However, even within 14 days of bottle-exposure, among 
the infants both breast and bottle-fed, the risk was increased. This observation suggests that limited 
exposure to bottle-feeding quickly results in a higher risk of PS. Although the point estimate for both 
breast and bottle-fed infants was lower than for the exclusively bottle-fed infants (never breastfed), 
there was no statistical difference. This suggests that breast milk provided little if any protective effect. 
On the basis of our study, it is not possible to determine whether it is the formula or the mechanism of 
bottle-feeding or both that make up the high risk. Formula has a higher level of whey and particularly 
casein proteins than breast milk and is likely more difficult for the infants to digest.34 Furthermore, the 
gastric emptying is affected by the composition of the feed and is slower in formula-fed infants.26, 35 The 
gastric and intestinal hormones may contribute to this difference.36 Bottle-fed infants consume a larger 
volume in less time. We therefore speculate that infants given formula by bottle ingest a larger volume 
of milk and retain it for a longer period of time in the stomach. This burden of overfeeding may 
challenge the pylorus muscle and lead to hypertrophy. Boy infants likewise may consume a larger 
volume or take food faster because they gain weight faster than girl infants.37, 38 If so, overfeeding might 
contribute to the higher risk of PS in boy infants. Formulas have been improved over time and now 
approach the composition of breast milk. This could be a contributing reason for the decrease in PS 
incidence. 
Strengths and Limitations 
Major strengths of this study included its design, size, and the utilization of unique Danish national 
registers. The detailed information in the Danish National Birth Cohort provided a unique opportunity to 
perform a large study with extensive information on breastfeeding status and adjustment for potential 
confounders by using information obtained before possible PS. PS diagnoses were obtained from the 
Danish National Patient Register in which hospital discharge diagnoses are mandatorily recorded for the 
entire country. In particular, surgical diagnoses must be considered both accurate and well-recorded.39 
In addition, we furthermore evaluated medical records to ensure the correctness of the diagnosis. We 
therefore consider misclassification of the diagnosis unlikely. 
However, some limitations should be considered in the interpretation of the observed association. 
Information about feeding practice was obtained 6 months after birth. Thus, the observed association 
could at least partly be explained by differential recall (ie, that mothers of infants who develop PS 
reported feeding practice differently compared with other mothers). However, it is difficult to imagine 
that these mothers on average should report the introduction of bottle-feeding 31 days (=122 days − 91 
days) earlier because of the disease of the infant. Furthermore, even though these mothers potentially 
could use the time of PS diagnosis to date the introduction of bottle-feeding more precisely, they did not 
more than expected report time of introduction of bottle-feeding by using the more precise form of 
weeks and days rather than months and weeks. We therefore do not find it likely that the higher risk of 
PS in bottle-fed infants can be ascribed to recall bias in the mothers. 
Another concern could be whether the observed higher risk of PS in bottle-fed infants occurred because 
mothers ended full breastfeeding due to disease symptoms in the infant (ie, inverse causality). However, 
we observed a similar increase in PS risk among infants who were first bottle-exposed close to PS 
surgery and those first exposed >30 days before PS surgery, well before symptoms were likely to have 
occurred. Furthermore, the infants who were never breastfed had the same high risk as infants who had 
formerly been breastfed. Therefore, inverse causality is not a likely explanation for our findings. 
 Finally, the observed difference in risk could in theory be due to a different risk factor profile in mothers 
who never breastfed their infants compared with those who breastfed (ie, confounding). However, with 
respect to gestational age, maternal age, the mother’s smoking habits, and other known variables, the 
group that never breastfed was similar in distribution to other cases. Furthermore, the difference in risk 
was also seen among breastfed children (eg, fully breastfed versus formerly breastfed). In addition, the 
minor effect of adjusting for the potentially most likely confounders did not support that the higher risk 
in bottle-fed infants can be ascribed to differences in risk profile. 
Thus, we find it unlikely that the risk association observed in this study was caused by either recall bias, 
inverse causality, or confounding. 
 
Conclusions 
We found that infants who were bottle-fed had a 4.6-fold increased risk of developing PS compared with 
infants who were not bottle-fed. The result adds to the evidence supporting the advantage of exclusive 
breastfeeding in the first months after birth. 
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